中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2012年
34期
177-178
,共2页
岳文涛%李世兴%娄学磊%常祖宽%牛永超%寇志平
嶽文濤%李世興%婁學磊%常祖寬%牛永超%寇誌平
악문도%리세흥%루학뢰%상조관%우영초%구지평
结肠癌%肝%转移%介入治疗
結腸癌%肝%轉移%介入治療
결장암%간%전이%개입치료
coloncarcinoma%metastasis%liver%chemoembolization interventional
目的探讨介入化疗栓塞方法治疗结肠癌肝转移的疗效.方法采用常规全身静脉化疗.结果介入化疗栓塞组有效率为88%(44/50)，全身静脉化疗组有效率为36.7%(11/30)，两组有显著的差异(P<0.01).介入化疗栓塞组50例6、12、24个月生存率为95.4%、76.8%、40.3%，单纯的静脉全身化疗组30例中6、12、24个月的生存率分别为59.7%、32.3%、14.8%.结论肝动脉化疗栓塞较全身静脉化疗疗效及生存期有明显提高.治疗组50例采用介入法肝动脉栓塞化疗，对照组30例
目的探討介入化療栓塞方法治療結腸癌肝轉移的療效.方法採用常規全身靜脈化療.結果介入化療栓塞組有效率為88%(44/50)，全身靜脈化療組有效率為36.7%(11/30)，兩組有顯著的差異(P<0.01).介入化療栓塞組50例6、12、24箇月生存率為95.4%、76.8%、40.3%，單純的靜脈全身化療組30例中6、12、24箇月的生存率分彆為59.7%、32.3%、14.8%.結論肝動脈化療栓塞較全身靜脈化療療效及生存期有明顯提高.治療組50例採用介入法肝動脈栓塞化療，對照組30例
목적탐토개입화료전새방법치료결장암간전이적료효.방법채용상규전신정맥화료.결과개입화료전새조유효솔위88%(44/50)，전신정맥화료조유효솔위36.7%(11/30)，량조유현저적차이(P<0.01).개입화료전새조50례6、12、24개월생존솔위95.4%、76.8%、40.3%，단순적정맥전신화료조30례중6、12、24개월적생존솔분별위59.7%、32.3%、14.8%.결론간동맥화료전새교전신정맥화료료효급생존기유명현제고.치료조50례채용개입법간동맥전새화료，대조조30례
Objective To study the therapeutic effects of chemoembolization for treatmen of liver metastases of colon carcinoma.Methods Hepatic arterial chemoembolization was performel in 50cases(study group),and systemic chemotherapy was given in 30cases(control group0.Results The complete remission rate plus patial remission rato was 88%(44/50)in study group,and 36.7%(11/30)in control group.The difference between two groups was statistically singnificant(P<0.01).For study group,the survival rate within 6,12and24 months was 95.4%,76.8%and40.3%,respectively,while for control group was 59.7%,32.3%and14.8%.Conclusion The interventional hepatic arterial chemoembolization can improve the survival period and enhanve the therapeutic effects in liver metastases of colon carcinomaw.conpared with conventional systemic chemotherapy.
